NCT07249905 2026-03-03Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of LymphomaModeX Therapeutics, An OPKO Health CompanyPhase 1/2 Recruiting180 enrolled
NCT06712810 2025-10-10Q702 for the Treatment of Patients With Hematologic MalignanciesMayo ClinicPhase 1 Recruiting46 enrolled